Christopher A. Newton

OverviewAI-generated summary

Christopher A. Newton's research focuses on developing novel therapeutic strategies and delivery systems for genetic disorders and chronic diseases. He is currently serving as PI on two NIH grants totaling over $608,000. One grant from the National Institute of General Medical Sciences, with $366,731 in funding, investigates the genomic and cellular factors that influence the durability of gene therapies. The second grant, from the National Institute of Biomedical Imaging and Bioengineering for $241,722, supports research into non-viral methods for delivering CRISPR/Cas9 gene-editing technology for targeted gene replacement.

His recent publications include work on nanofiltration for artificial kidney devices, analysis of clinical characteristics in idiopathic pulmonary fibrosis patients, and the role of cytokine profiles in interstitial pneumonia with autoimmune features. These publications indicate a broad interest in medical applications, ranging from organ support technologies to understanding complex disease pathogenesis. Newton's work involves collaborations with other researchers at the University of Arkansas at Fayetteville, including Jamie Hestekin, Christa N. Hestekin, and Haley Duncan, with whom he shares publications.

With an h-index of 24 and over 2,400 citations across 43 publications, Newton is recognized as a highly cited researcher. His active lab website suggests an ongoing commitment to research and mentorship.

Metrics

• h-index: 25
• Publications: 43
• Citations: 2,475